COMPARATIVE STUDY OF EFFICACY OF COMBINED TREATMENT WITH KETOCONAZOLE 2% CREAM AND ADAPALENE 0.1% GEL VS. KETOCONAZOLE 2% CREAM MONOTHERAPY IN PITYRIASIS VERSICOLOR
DOI:
https://doi.org/10.47672/ajhmn.1029Keywords:
Ketoconazole 2%, Adapalene, Efficacy, Malassezia spp., Pityriasis versicolor.Abstract
Background: Pityriasis Versicolor (PV) is an infection of the superficial layers of skin caused by Malassezia yeasts. It is a non-contagious disease characterized by hypo and hyperpigmented macules on the body. Up to 40% of people face itching, decreased quality of life, social stigmatization, and embarrassment due to the lesions. Adapalene with Ketoconazole provides an efficient option for PV patients due to better toxicity profile and rapid action on the lesions.
Objective: Comparison of efficacy of combined therapy with Ketoconazole 2% cream and adapalene 1% gel against Ketoconazole 2% cream monotherapy in Pityriasis Versicolor.
Methods: Total 90 patients (45 in each group) were included in the study. Group-A was treated with combination of Ketoconazole 2% cream & adapalene 1% gel while group-B was given Ketoconazole 2% cream monotherapy. Study design was randomized controlled trial and SPSS version 26 was used for data analysis.
Results: Mean age of the patients was 24.3±4.3 and 23.3±3.9 years in group-A and B, respectively. There were 30 males (66.7%) & 15 females (33.3%) in group-A while 35 males (77.8%) and 10 females (22.2%) in group-B. Mean duration of disease was 2.0±0.9 months in group-A & 2.3±1.2 months in group-B.The efficacy of combined therapy with Ketoconazole 2% cream & adapalene 1% gel was found to be better when compared with Ketoconazole 2% cream monotherapy in Pityriasis Versicolor. Difference between two groups (p=0.011) was statistically significant.
Conclusion: It was concluded that adapalene 0.1% gel & ketoconazole 2% cream in combination is more effective than ketoconazole 2% cream monotherapy in the treatment of PV.
Recommendation: It is recommended to use a combination of adapalene 0.1% gel & ketoconazole 2% cream than ketoconazole 2% cream monotherapy in the treatment of PV.
Downloads
References
Mathur M, Acharya P, Karki A, Kc N, Shah J. Dermoscopic pattern of pityriasis versicolor. Clin Cosmet Investig Dermatol. 2019 Apr 30;12:303-309.
Munir A, Akbar N, ur Rehman F. Frequency of hair loss in lesions of pityriasis versicolor. J Pakistan Assoc Dermatol. 2019;28:526-31.
Sharma A, Rabha D, Choraria S, Hazarika D, Ahmed G, Hazarika NK. Clinicomycological profile of pityriasis versicolor in Assam. Indian J Pathol Microbiol. 2016;59:159-65.
Bamford JTM, Flores‐Genuino RNS, Ray S, Bigby M, Morales‐Sánchez MA, Arkoncel M, et al. Interventions for the treatment of pityriasis versicolor. Cochrane Database Syst Rev. 2018; 2018:CD011208.
Rios-Yuil JM. Pityriasis Versicolor: Clinical Spectrum and Diagnosis. Curr Fungal Infec Reports. 2016;10:121-5.
Elshabrawy WO, Saudy N, Sallam M. Molecular and Phenotypic Identification and Speciation of Malassezia Yeasts Isolated from Egyptian Patients with Pityriasis Versicolor. J Clin Diagn Res. 2017;11:DC12-DC17.
Angiolella L, Carradori S, Maccallini C, Giusiano G, T Supuran C. Targeting Malassezia species for novel synthetic and natural antidandruff agents. Curr Med Chemistry. 2017;24:2392-412.
Naeem M, Latif A, Afgan S. Prevalence of pityriasis versicolor and its association of abo blood groups in opd patients of Islam teaching hospital Sialkot. In Med. Forum Mon 2016 May (Vol. 27, No. 5, pp. 16-18).
Bakr E, Abdo H, Abd‐Elaziz H, Abd‐Elrazek H, Amer M. Adapalene gel 0.1% vs ketoconazole cream 2% and their combination in the treatment of pityriasis versicolor: A randomized clinical study. Dermatologic Therapy. 2020;17:e13319.
Plensdorf S, Livieratos M, Dada N. Pigmentation disorders: Diagnosis and management. American family physician. 2017;96:797-804.
Ramezanli T, Michniak-Kohn BB. Development and Characterization of a Topical Gel Formulation of Adapalene-TyroSpheres and Assessment of Its Clinical Efficacy. Molecular pharmaceutics. 2018;15:3813-22.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Sadia Hameed, Mohammad Majid Paracha, Farah Sagheer, Abdul Qayum Khan, Sahibzada Mahmood Noor
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgment of the work’s authorship and initial publication in this journal.
